Serum lipids and lipoproteins in relation to restenosis after coronary angioplasty

Related Experiment Video

Updated: May 5, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

27.4K

S R Johansson1, O Wiklund, T Karlsson

  • 1Department of Medicine I, University of Göteborg, Sweden.

European Heart Journal
|September 1, 1991
PubMed

Insights

Restenosis after angioplasty is common. This study found no link between cholesterol, triglycerides, or LDL levels and restenosis, but HDL levels showed gender-specific associations.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Lipid Metabolism

Background:

  • Restenosis following percutaneous coronary angioplasty (PTCA) significantly limits long-term procedure success.
  • Lipoprotein levels, implicated in atherosclerosis, are investigated for their potential role in restenosis.
  • Understanding factors influencing restenosis is crucial for improving patient outcomes after PTCA.

Purpose of the Study:

  • To investigate the association between serum lipid levels (cholesterol, triglycerides, HDL, LDL) and the occurrence of restenosis after PTCA.
  • To identify clinical and angiographic predictors of restenosis in patients undergoing PTCA.
  • To explore potential gender-specific relationships between lipid profiles and restenosis.

Main Methods:

  • Serum levels of cholesterol (CH), triglycerides (TG), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) were measured in 157 patients undergoing 161 PTCA procedures.
  • Follow-up coronary angiograms were performed approximately 6 months post-procedure to assess for restenosis.
  • Statistical analyses, including univariate and multivariate approaches, were used to evaluate associations between lipid levels, clinical factors, and restenosis rates, with separate analyses for males and females.

Main Results:

  • The overall restenosis rate after PTCA was 33%.
  • Treatment with aspirin and residual stenosis between 25-49% post-PTCA were the only significant predictors of restenosis (P < 0.05).
  • No significant relationship was found between overall restenosis and serum levels of CH, TG, HDL, or LDL (P > 0.05). However, low HDL was associated with restenosis in men, while high HDL was associated in women (P < 0.05).

Conclusions:

  • Serum levels of cholesterol, triglycerides, and LDL do not appear to be directly related to restenosis after PTCA.
  • Gender-specific associations suggest that low HDL in males and high HDL in females may be linked to restenosis.
  • Further research is warranted to elucidate the complex relationship between HDL levels and restenosis in different genders.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

4.9K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
854
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741